- Home
- FNWB vs AVTX Comparison
FNWB vs AVTX Comparison
Compare FNWB & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- AVTX
- Stock Information
- Founded
- FNWB 1923
- AVTX 2011
- Country
- FNWB United States
- AVTX United States
- Employees
- FNWB N/A
- AVTX N/A
- Industry
- FNWB Banks
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- FNWB Finance
- AVTX Health Care
- Exchange
- FNWB Nasdaq
- AVTX Nasdaq
- Market Cap
- FNWB 69.0M
- AVTX 248.3M
- IPO Year
- FNWB 2015
- AVTX 2015
- Fundamental
- Price
- FNWB $7.84
- AVTX $13.69
- Analyst Decision
- FNWB Hold
- AVTX Strong Buy
- Analyst Count
- FNWB 1
- AVTX 9
- Target Price
- FNWB $12.00
- AVTX $30.14
- AVG Volume (30 Days)
- FNWB 24.4K
- AVTX 505.6K
- Earning Date
- FNWB 10-28-2025
- AVTX 11-06-2025
- Dividend Yield
- FNWB 3.56%
- AVTX N/A
- EPS Growth
- FNWB N/A
- AVTX N/A
- EPS
- FNWB N/A
- AVTX N/A
- Revenue
- FNWB $48,874,000.00
- AVTX $441,000.00
- Revenue This Year
- FNWB $34.16
- AVTX N/A
- Revenue Next Year
- FNWB $11.73
- AVTX N/A
- P/E Ratio
- FNWB N/A
- AVTX N/A
- Revenue Growth
- FNWB N/A
- AVTX N/A
- 52 Week Low
- FNWB $6.05
- AVTX $3.39
- 52 Week High
- FNWB $12.10
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- FNWB 55.60
- AVTX 60.05
- Support Level
- FNWB $7.76
- AVTX $13.42
- Resistance Level
- FNWB $8.10
- AVTX $15.99
- Average True Range (ATR)
- FNWB 0.22
- AVTX 1.20
- MACD
- FNWB 0.04
- AVTX 0.06
- Stochastic Oscillator
- FNWB 51.28
- AVTX 56.16
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).